nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—Cladribine—Fludarabine—lymphatic system cancer	0.321	0.526	CrCrCtD
Floxuridine—Decitabine—Cytarabine—lymphatic system cancer	0.289	0.474	CrCrCtD
Floxuridine—TYMS—Methotrexate—lymphatic system cancer	0.24	1	CbGbCtD
Floxuridine—Skin toxicity—Fludarabine—lymphatic system cancer	0.012	0.0831	CcSEcCtD
Floxuridine—Aneurysm—Fludarabine—lymphatic system cancer	0.00954	0.066	CcSEcCtD
Floxuridine—Skin toxicity—Bleomycin—lymphatic system cancer	0.0088	0.0609	CcSEcCtD
Floxuridine—Nail changes—Bleomycin—lymphatic system cancer	0.00699	0.0484	CcSEcCtD
Floxuridine—Cerebellar syndrome—Fludarabine—lymphatic system cancer	0.0069	0.0477	CcSEcCtD
Floxuridine—Nail changes—Methotrexate—lymphatic system cancer	0.00283	0.0196	CcSEcCtD
Floxuridine—Enteritis—Mitoxantrone—lymphatic system cancer	0.00241	0.0167	CcSEcCtD
Floxuridine—Ischaemia—Mitoxantrone—lymphatic system cancer	0.00226	0.0156	CcSEcCtD
Floxuridine—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.00179	0.0124	CcSEcCtD
Floxuridine—TYMS—Podofilox—Teniposide—lymphatic system cancer	0.00179	0.4	CbGdCrCtD
Floxuridine—Nail disorder—Bleomycin—lymphatic system cancer	0.00156	0.0108	CcSEcCtD
Floxuridine—Arterial thrombosis—Methotrexate—lymphatic system cancer	0.00152	0.0105	CcSEcCtD
Floxuridine—Pancytopenia—Mechlorethamine—lymphatic system cancer	0.00127	0.0088	CcSEcCtD
Floxuridine—Enteritis—Methotrexate—lymphatic system cancer	0.0012	0.00831	CcSEcCtD
Floxuridine—Nystagmus—Vincristine—lymphatic system cancer	0.00118	0.00819	CcSEcCtD
Floxuridine—Abscess—Carmustine—lymphatic system cancer	0.00112	0.00774	CcSEcCtD
Floxuridine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00112	0.00771	CcSEcCtD
Floxuridine—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00108	0.00746	CcSEcCtD
Floxuridine—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00107	0.00742	CcSEcCtD
Floxuridine—TYMS—Vinorelbine—Vincristine—lymphatic system cancer	0.00106	0.238	CbGdCrCtD
Floxuridine—Myocardial ischaemia—Mitoxantrone—lymphatic system cancer	0.00102	0.00709	CcSEcCtD
Floxuridine—Alopecia—Mechlorethamine—lymphatic system cancer	0.000948	0.00656	CcSEcCtD
Floxuridine—Pancytopenia—Teniposide—lymphatic system cancer	0.000938	0.00649	CcSEcCtD
Floxuridine—Stomatitis—Teniposide—lymphatic system cancer	0.000859	0.00594	CcSEcCtD
Floxuridine—Angina pectoris—Fludarabine—lymphatic system cancer	0.000846	0.00585	CcSEcCtD
Floxuridine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.000836	0.00578	CcSEcCtD
Floxuridine—Pancytopenia—Fludarabine—lymphatic system cancer	0.000825	0.0057	CcSEcCtD
Floxuridine—Disorientation—Bleomycin—lymphatic system cancer	0.000823	0.0057	CcSEcCtD
Floxuridine—Haemoglobin—Teniposide—lymphatic system cancer	0.000795	0.0055	CcSEcCtD
Floxuridine—Haemorrhage—Teniposide—lymphatic system cancer	0.000791	0.00547	CcSEcCtD
Floxuridine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.000762	0.00527	CcSEcCtD
Floxuridine—Infection—Mechlorethamine—lymphatic system cancer	0.000757	0.00524	CcSEcCtD
Floxuridine—Stomatitis—Fludarabine—lymphatic system cancer	0.000755	0.00522	CcSEcCtD
Floxuridine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.000746	0.00516	CcSEcCtD
Floxuridine—Thrombophlebitis—Carmustine—lymphatic system cancer	0.000743	0.00514	CcSEcCtD
Floxuridine—TYMS—Vinblastine—Vincristine—lymphatic system cancer	0.000731	0.164	CbGdCrCtD
Floxuridine—Epistaxis—Fludarabine—lymphatic system cancer	0.00073	0.00505	CcSEcCtD
Floxuridine—Anorexia—Mechlorethamine—lymphatic system cancer	0.000726	0.00502	CcSEcCtD
Floxuridine—Alopecia—Teniposide—lymphatic system cancer	0.000699	0.00483	CcSEcCtD
Floxuridine—Haemoglobin—Fludarabine—lymphatic system cancer	0.000699	0.00483	CcSEcCtD
Floxuridine—Haemorrhage—Fludarabine—lymphatic system cancer	0.000695	0.00481	CcSEcCtD
Floxuridine—Pharyngitis—Fludarabine—lymphatic system cancer	0.00069	0.00477	CcSEcCtD
Floxuridine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.000662	0.00458	CcSEcCtD
Floxuridine—Embolism—Methotrexate—lymphatic system cancer	0.000639	0.00442	CcSEcCtD
Floxuridine—Anaemia—Teniposide—lymphatic system cancer	0.000636	0.0044	CcSEcCtD
Floxuridine—Nail disorder—Methotrexate—lymphatic system cancer	0.000633	0.00438	CcSEcCtD
Floxuridine—Leukopenia—Teniposide—lymphatic system cancer	0.000616	0.00426	CcSEcCtD
Floxuridine—Alopecia—Fludarabine—lymphatic system cancer	0.000614	0.00425	CcSEcCtD
Floxuridine—Pancytopenia—Bleomycin—lymphatic system cancer	0.000605	0.00418	CcSEcCtD
Floxuridine—Confusional state—Teniposide—lymphatic system cancer	0.000566	0.00392	CcSEcCtD
Floxuridine—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.000561	0.00388	CcSEcCtD
Floxuridine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.000561	0.00388	CcSEcCtD
Floxuridine—Anaemia—Fludarabine—lymphatic system cancer	0.000559	0.00387	CcSEcCtD
Floxuridine—Infection—Teniposide—lymphatic system cancer	0.000558	0.00386	CcSEcCtD
Floxuridine—Stomatitis—Bleomycin—lymphatic system cancer	0.000553	0.00383	CcSEcCtD
Floxuridine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00055	0.00381	CcSEcCtD
Floxuridine—Malaise—Fludarabine—lymphatic system cancer	0.000546	0.00377	CcSEcCtD
Floxuridine—Leukopenia—Fludarabine—lymphatic system cancer	0.000542	0.00375	CcSEcCtD
Floxuridine—Anorexia—Teniposide—lymphatic system cancer	0.000536	0.0037	CcSEcCtD
Floxuridine—Pancytopenia—Carmustine—lymphatic system cancer	0.000528	0.00365	CcSEcCtD
Floxuridine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000521	0.00361	CcSEcCtD
Floxuridine—Abscess—Methotrexate—lymphatic system cancer	0.000519	0.00359	CcSEcCtD
Floxuridine—Haemoglobin—Bleomycin—lymphatic system cancer	0.000512	0.00354	CcSEcCtD
Floxuridine—Haemorrhage—Bleomycin—lymphatic system cancer	0.00051	0.00352	CcSEcCtD
Floxuridine—Discomfort—Fludarabine—lymphatic system cancer	0.000509	0.00352	CcSEcCtD
Floxuridine—Pancytopenia—Vincristine—lymphatic system cancer	0.000504	0.00348	CcSEcCtD
Floxuridine—Confusional state—Fludarabine—lymphatic system cancer	0.000498	0.00344	CcSEcCtD
Floxuridine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000494	0.00342	CcSEcCtD
Floxuridine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000491	0.00339	CcSEcCtD
Floxuridine—Infection—Fludarabine—lymphatic system cancer	0.000491	0.00339	CcSEcCtD
Floxuridine—Decreased appetite—Teniposide—lymphatic system cancer	0.000488	0.00338	CcSEcCtD
Floxuridine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000485	0.00335	CcSEcCtD
Floxuridine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000484	0.00335	CcSEcCtD
Floxuridine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.000484	0.00335	CcSEcCtD
Floxuridine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000483	0.00334	CcSEcCtD
Floxuridine—Stomatitis—Carmustine—lymphatic system cancer	0.000483	0.00334	CcSEcCtD
Floxuridine—Rash—Mechlorethamine—lymphatic system cancer	0.00048	0.00332	CcSEcCtD
Floxuridine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00048	0.00332	CcSEcCtD
Floxuridine—Anorexia—Fludarabine—lymphatic system cancer	0.000471	0.00326	CcSEcCtD
Floxuridine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000463	0.0032	CcSEcCtD
Floxuridine—Stomatitis—Vincristine—lymphatic system cancer	0.000461	0.00319	CcSEcCtD
Floxuridine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000459	0.00318	CcSEcCtD
Floxuridine—TYMS—Azacitidine—Fludarabine—lymphatic system cancer	0.000453	0.102	CbGdCrCtD
Floxuridine—Nausea—Mechlorethamine—lymphatic system cancer	0.000453	0.00313	CcSEcCtD
Floxuridine—Alopecia—Bleomycin—lymphatic system cancer	0.00045	0.00311	CcSEcCtD
Floxuridine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000449	0.00311	CcSEcCtD
Floxuridine—Haemoglobin—Carmustine—lymphatic system cancer	0.000447	0.00309	CcSEcCtD
Floxuridine—Glossitis—Methotrexate—lymphatic system cancer	0.000445	0.00308	CcSEcCtD
Floxuridine—Haemorrhage—Carmustine—lymphatic system cancer	0.000445	0.00308	CcSEcCtD
Floxuridine—Abdominal pain—Teniposide—lymphatic system cancer	0.000444	0.00307	CcSEcCtD
Floxuridine—Body temperature increased—Teniposide—lymphatic system cancer	0.000444	0.00307	CcSEcCtD
Floxuridine—Erythema—Bleomycin—lymphatic system cancer	0.000444	0.00307	CcSEcCtD
Floxuridine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00043	0.00297	CcSEcCtD
Floxuridine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000429	0.00297	CcSEcCtD
Floxuridine—TYMS—Azacitidine—Cytarabine—lymphatic system cancer	0.000428	0.096	CbGdCrCtD
Floxuridine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000416	0.00287	CcSEcCtD
Floxuridine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000414	0.00286	CcSEcCtD
Floxuridine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000414	0.00286	CcSEcCtD
Floxuridine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000412	0.00285	CcSEcCtD
Floxuridine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00041	0.00284	CcSEcCtD
Floxuridine—Anaemia—Bleomycin—lymphatic system cancer	0.00041	0.00284	CcSEcCtD
Floxuridine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000407	0.00281	CcSEcCtD
Floxuridine—Asthenia—Teniposide—lymphatic system cancer	0.000403	0.00279	CcSEcCtD
Floxuridine—Malaise—Bleomycin—lymphatic system cancer	0.0004	0.00277	CcSEcCtD
Floxuridine—Leukopenia—Bleomycin—lymphatic system cancer	0.000397	0.00275	CcSEcCtD
Floxuridine—Alopecia—Carmustine—lymphatic system cancer	0.000393	0.00272	CcSEcCtD
Floxuridine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00039	0.0027	CcSEcCtD
Floxuridine—Erythema—Carmustine—lymphatic system cancer	0.000387	0.00268	CcSEcCtD
Floxuridine—Diarrhoea—Teniposide—lymphatic system cancer	0.000384	0.00266	CcSEcCtD
Floxuridine—Alopecia—Vincristine—lymphatic system cancer	0.000375	0.0026	CcSEcCtD
Floxuridine—Discomfort—Bleomycin—lymphatic system cancer	0.000373	0.00258	CcSEcCtD
Floxuridine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000365	0.00253	CcSEcCtD
Floxuridine—Confusional state—Bleomycin—lymphatic system cancer	0.000365	0.00253	CcSEcCtD
Floxuridine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000364	0.00252	CcSEcCtD
Floxuridine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000362	0.0025	CcSEcCtD
Floxuridine—Erythema—Mitoxantrone—lymphatic system cancer	0.00036	0.00249	CcSEcCtD
Floxuridine—Infection—Bleomycin—lymphatic system cancer	0.00036	0.00249	CcSEcCtD
Floxuridine—Anaemia—Carmustine—lymphatic system cancer	0.000358	0.00248	CcSEcCtD
Floxuridine—Vomiting—Teniposide—lymphatic system cancer	0.000357	0.00247	CcSEcCtD
Floxuridine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000354	0.00245	CcSEcCtD
Floxuridine—Asthenia—Fludarabine—lymphatic system cancer	0.000354	0.00245	CcSEcCtD
Floxuridine—Rash—Teniposide—lymphatic system cancer	0.000354	0.00245	CcSEcCtD
Floxuridine—Dermatitis—Teniposide—lymphatic system cancer	0.000354	0.00245	CcSEcCtD
Floxuridine—Headache—Teniposide—lymphatic system cancer	0.000352	0.00243	CcSEcCtD
Floxuridine—Leukopenia—Carmustine—lymphatic system cancer	0.000347	0.0024	CcSEcCtD
Floxuridine—Anorexia—Bleomycin—lymphatic system cancer	0.000345	0.00239	CcSEcCtD
Floxuridine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000344	0.00238	CcSEcCtD
Floxuridine—Anaemia—Vincristine—lymphatic system cancer	0.000342	0.00236	CcSEcCtD
Floxuridine—Photosensitivity—Methotrexate—lymphatic system cancer	0.000339	0.00235	CcSEcCtD
Floxuridine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000338	0.00234	CcSEcCtD
Floxuridine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000334	0.00231	CcSEcCtD
Floxuridine—Nausea—Teniposide—lymphatic system cancer	0.000334	0.00231	CcSEcCtD
Floxuridine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000333	0.0023	CcSEcCtD
Floxuridine—Leukopenia—Vincristine—lymphatic system cancer	0.000331	0.00229	CcSEcCtD
Floxuridine—Malaise—Mitoxantrone—lymphatic system cancer	0.000325	0.00225	CcSEcCtD
Floxuridine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000322	0.00223	CcSEcCtD
Floxuridine—Confusional state—Carmustine—lymphatic system cancer	0.000319	0.0022	CcSEcCtD
Floxuridine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000315	0.00218	CcSEcCtD
Floxuridine—Infection—Carmustine—lymphatic system cancer	0.000314	0.00217	CcSEcCtD
Floxuridine—Vomiting—Fludarabine—lymphatic system cancer	0.000314	0.00217	CcSEcCtD
Floxuridine—Rash—Fludarabine—lymphatic system cancer	0.000311	0.00215	CcSEcCtD
Floxuridine—Dermatitis—Fludarabine—lymphatic system cancer	0.000311	0.00215	CcSEcCtD
Floxuridine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000309	0.00214	CcSEcCtD
Floxuridine—Headache—Fludarabine—lymphatic system cancer	0.000309	0.00214	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—lymphatic system cancer	0.000304	0.0021	CcSEcCtD
Floxuridine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000303	0.00209	CcSEcCtD
Floxuridine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000302	0.00209	CcSEcCtD
Floxuridine—Anorexia—Carmustine—lymphatic system cancer	0.000301	0.00208	CcSEcCtD
Floxuridine—Infection—Vincristine—lymphatic system cancer	0.0003	0.00207	CcSEcCtD
Floxuridine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000298	0.00206	CcSEcCtD
Floxuridine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000296	0.00205	CcSEcCtD
Floxuridine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000296	0.00205	CcSEcCtD
Floxuridine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000295	0.00204	CcSEcCtD
Floxuridine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000294	0.00203	CcSEcCtD
Floxuridine—Nausea—Fludarabine—lymphatic system cancer	0.000293	0.00203	CcSEcCtD
Floxuridine—Infection—Mitoxantrone—lymphatic system cancer	0.000292	0.00202	CcSEcCtD
Floxuridine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000288	0.00199	CcSEcCtD
Floxuridine—Anorexia—Vincristine—lymphatic system cancer	0.000288	0.00199	CcSEcCtD
Floxuridine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000286	0.00198	CcSEcCtD
Floxuridine—Anorexia—Mitoxantrone—lymphatic system cancer	0.00028	0.00194	CcSEcCtD
Floxuridine—Decreased appetite—Carmustine—lymphatic system cancer	0.000275	0.0019	CcSEcCtD
Floxuridine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000267	0.00185	CcSEcCtD
Floxuridine—Decreased appetite—Vincristine—lymphatic system cancer	0.000262	0.00181	CcSEcCtD
Floxuridine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00026	0.0018	CcSEcCtD
Floxuridine—Asthenia—Bleomycin—lymphatic system cancer	0.00026	0.0018	CcSEcCtD
Floxuridine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000258	0.00179	CcSEcCtD
Floxuridine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000255	0.00177	CcSEcCtD
Floxuridine—Abdominal pain—Carmustine—lymphatic system cancer	0.00025	0.00173	CcSEcCtD
Floxuridine—Body temperature increased—Carmustine—lymphatic system cancer	0.00025	0.00173	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000247	0.00171	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000244	0.00169	CcSEcCtD
Floxuridine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000242	0.00167	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00024	0.00166	CcSEcCtD
Floxuridine—Abdominal pain—Vincristine—lymphatic system cancer	0.000238	0.00165	CcSEcCtD
Floxuridine—Body temperature increased—Vincristine—lymphatic system cancer	0.000238	0.00165	CcSEcCtD
Floxuridine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000235	0.00163	CcSEcCtD
Floxuridine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000233	0.00161	CcSEcCtD
Floxuridine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000232	0.00161	CcSEcCtD
Floxuridine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000232	0.00161	CcSEcCtD
Floxuridine—Vomiting—Bleomycin—lymphatic system cancer	0.00023	0.00159	CcSEcCtD
Floxuridine—Rash—Bleomycin—lymphatic system cancer	0.000228	0.00158	CcSEcCtD
Floxuridine—Dermatitis—Bleomycin—lymphatic system cancer	0.000228	0.00158	CcSEcCtD
Floxuridine—Asthenia—Carmustine—lymphatic system cancer	0.000227	0.00157	CcSEcCtD
Floxuridine—Stomatitis—Methotrexate—lymphatic system cancer	0.000224	0.00155	CcSEcCtD
Floxuridine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000222	0.00154	CcSEcCtD
Floxuridine—Epistaxis—Methotrexate—lymphatic system cancer	0.000216	0.0015	CcSEcCtD
Floxuridine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000216	0.0015	CcSEcCtD
Floxuridine—Asthenia—Vincristine—lymphatic system cancer	0.000216	0.0015	CcSEcCtD
Floxuridine—Diarrhoea—Carmustine—lymphatic system cancer	0.000216	0.0015	CcSEcCtD
Floxuridine—Nausea—Bleomycin—lymphatic system cancer	0.000215	0.00149	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000214	0.00148	CcSEcCtD
Floxuridine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000211	0.00146	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000207	0.00143	CcSEcCtD
Floxuridine—Diarrhoea—Vincristine—lymphatic system cancer	0.000206	0.00143	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000206	0.00143	CcSEcCtD
Floxuridine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000204	0.00141	CcSEcCtD
Floxuridine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000201	0.00139	CcSEcCtD
Floxuridine—Vomiting—Carmustine—lymphatic system cancer	0.000201	0.00139	CcSEcCtD
Floxuridine—Rash—Carmustine—lymphatic system cancer	0.000199	0.00138	CcSEcCtD
Floxuridine—Dermatitis—Carmustine—lymphatic system cancer	0.000199	0.00138	CcSEcCtD
Floxuridine—Headache—Carmustine—lymphatic system cancer	0.000198	0.00137	CcSEcCtD
Floxuridine—Vomiting—Vincristine—lymphatic system cancer	0.000192	0.00133	CcSEcCtD
Floxuridine—Rash—Vincristine—lymphatic system cancer	0.00019	0.00132	CcSEcCtD
Floxuridine—Dermatitis—Vincristine—lymphatic system cancer	0.00019	0.00131	CcSEcCtD
Floxuridine—Headache—Vincristine—lymphatic system cancer	0.000189	0.00131	CcSEcCtD
Floxuridine—Nausea—Carmustine—lymphatic system cancer	0.000188	0.0013	CcSEcCtD
Floxuridine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000187	0.00129	CcSEcCtD
Floxuridine—Rash—Mitoxantrone—lymphatic system cancer	0.000185	0.00128	CcSEcCtD
Floxuridine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000185	0.00128	CcSEcCtD
Floxuridine—Headache—Mitoxantrone—lymphatic system cancer	0.000184	0.00127	CcSEcCtD
Floxuridine—Alopecia—Methotrexate—lymphatic system cancer	0.000182	0.00126	CcSEcCtD
Floxuridine—Erythema—Methotrexate—lymphatic system cancer	0.000179	0.00124	CcSEcCtD
Floxuridine—Nausea—Vincristine—lymphatic system cancer	0.000179	0.00124	CcSEcCtD
Floxuridine—Nausea—Mitoxantrone—lymphatic system cancer	0.000175	0.00121	CcSEcCtD
Floxuridine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000166	0.00115	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—lymphatic system cancer	0.000166	0.00115	CcSEcCtD
Floxuridine—Malaise—Methotrexate—lymphatic system cancer	0.000162	0.00112	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—lymphatic system cancer	0.000161	0.00111	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—lymphatic system cancer	0.000151	0.00104	CcSEcCtD
Floxuridine—Confusional state—Methotrexate—lymphatic system cancer	0.000148	0.00102	CcSEcCtD
Floxuridine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000146	0.00101	CcSEcCtD
Floxuridine—Infection—Methotrexate—lymphatic system cancer	0.000145	0.00101	CcSEcCtD
Floxuridine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000144	0.000993	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000143	0.000991	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—lymphatic system cancer	0.00014	0.000965	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000127	0.00088	CcSEcCtD
Floxuridine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000121	0.000834	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00012	0.000828	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000116	0.0008	CcSEcCtD
Floxuridine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000116	0.0008	CcSEcCtD
Floxuridine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000108	0.000746	CcSEcCtD
Floxuridine—Asthenia—Methotrexate—lymphatic system cancer	0.000105	0.000726	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—lymphatic system cancer	0.0001	0.000693	CcSEcCtD
Floxuridine—Vomiting—Methotrexate—lymphatic system cancer	9.31e-05	0.000644	CcSEcCtD
Floxuridine—Rash—Methotrexate—lymphatic system cancer	9.23e-05	0.000638	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—lymphatic system cancer	9.22e-05	0.000638	CcSEcCtD
Floxuridine—Headache—Methotrexate—lymphatic system cancer	9.17e-05	0.000634	CcSEcCtD
Floxuridine—Nausea—Methotrexate—lymphatic system cancer	8.69e-05	0.000601	CcSEcCtD
